For seniors in the midst of Medicare open enrollment, which lasts this year from October 15 to December 7, questions remain about how a Trump presidency will affect Medicare. The president-elect made clear his intention to repeal the Affordable Care Act throughout his campaign and has since established a page on his website dedicated to his plans to reshape the nation’s healthcare system. He includes steps to “modernize Medicare” and increase state flexibility with regard to Medicaid. Trump promised throughout his campaign to leave Medicare untouched, though his campaign seems to be leaving the door open to some reforms.
Pharmaceutical stocks have gained in the days since Trump’s surprise victory over Hillary Clinton last Tuesday. President-elect Trump continues to call for a replacement to the Affordable Care Act though he has yet to offer a specific plan nor clarified how he plans to combat the rising medication and health care costs for most Americans. Regardless, any changes have the potential to greatly impact the drug marketplace and the drug price issue is unlikely to go away in the coming years. During the Republican primary presidential campaign, Trump indicated that he was open to having the federal government negotiate directly with pharmaceutical companies to secure lower prices, as other nations such as Canada do. It is unclear if this remains part of Trump’s plan or was merely an idea proposed on the campaign trail.